News FDA publishes advice on animal testing alternatives New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to non-animal alternatives.
R&D Making AI work where it matters, with Rob DiCicco Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, discusses barriers and the breakthroughs in making AI work.
News FDA plans to phase out animal testing for antibodies The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.
News BenchSci raises $50m to grow AI-powered R&D platform Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical rese
Partner Content Partner Content Medicines Discovery Catapult’s Discovery Services platform a... Virtual R&D Discovery Services platform
Partner Content Partner Content Unrivalled imaging capabilities now available to accelerate ... Unrivalled imaging capabilities now available
R&D LSX2026: Non-opioid pain relief and pharma positivity, with ... Mike Cooke, CEO of AmacaThera, spoke with pharmaphorum at the LSX World Congress, including about non-opioid pain relief.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.